Literature DB >> 17593477

In vivo reduction of the nuclear factor-kappaB activity using synthetic cis-element decoy oligonucleotides suppresses intimal hyperplasia in the injured carotid arteries in rabbits.

Kensuke Takeuchi1, Hiroyuki Itoh, Yoshikazu Yonemitsu, Takuya Matsumoto, Masazumi Kume, Kimihiro Komori, Yoshihiko Maehara.   

Abstract

PURPOSE: Nuclear factor-kappaB (NF-kappaB) plays a critical role in inflammation-related reactions, and is also found in the injured arterial wall. The purpose of this study was to introduce synthetic double-stranded cis-element "decoy" oligonucleotides (ODNs) into the arterial wall using the hemagglutinating virus of Japan (HVJ) liposome, and to investigate the inhibitory potential of decoy ODN against balloon injury-induced intimal hyperplasia by reducing NF-kappaB activity.
METHODS: Fluorescein isothiocyanate (FITC)-labeled decoy ODNs using the HVJ-liposome method were tranfected in balloon-injured rabbit carotid arteries. We then performed electrophoretic mobility shift assay to examine NF-kappaB activity using balloon-injured arteries, and we introduced NF-kappaB decoy into balloon-injured arteries.
RESULTS: Transfection of FITC-labeled decoy ODNs by using the HVJ-liposome method demonstrated highly efficient protein expression with diffuse, frequent, and widespread nuclear signals over the entire medial layer, while the same amount of naked ODNs showed much less efficiency with scattered distribution of fluorescence in balloon-injured carotid arteries. Electrophoretic mobility shift assay showed activation of NF-kappaB in balloon-injured arteries. In vivo transfection of decoy ODNs mediated by HVJ liposome abolished the NF-kappaB activity in injured arteries with specific binding affinity to NF-kappaB protein. Intimal hyperplasia of carotid artery after balloon injury was reduced by approximately 50% by NF-kappaB decoy transfection compared with buffer treatment or scrambled decoy transfection.
CONCLUSION: Our results demonstrated involvement of NF-kappaB in intimal formation after arterial injury, and indicated that NF-kappaB can be an appropriate molecular target for anti-restenosis therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17593477     DOI: 10.1007/s00595-007-3469-9

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.540


  43 in total

1.  IKKbeta-dependent NF-kappaB pathway controls vascular inflammation and intimal hyperplasia.

Authors:  De-xiu Bu; Wolfgang Erl; Rainer de Martin; Göran K Hansson; Zhong-qun Yan
Journal:  FASEB J       Date:  2005-06-06       Impact factor: 5.191

2.  Molecular and functional interactions of transcription factor USF with the long terminal repeat of human immunodeficiency virus type 1.

Authors:  F d'Adda di Fagagna; G Marzio; M I Gutierrez; L Y Kang; A Falaschi; M Giacca
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

Review 3.  Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture.

Authors:  M R Bennett
Journal:  Cardiovasc Res       Date:  1999-02       Impact factor: 10.787

4.  Polymeric-based perivascular delivery of a nitric oxide donor inhibits intimal thickening after balloon denudation arterial injury: role of nuclear factor-kappaB.

Authors:  S Kaul; B Cercek; J Rengstrom; X P Xu; M D Molloy; P Dimayuga; A K Parikh; M C Fishbein; J Nilsson; T B Rajavashisth; P K Shah
Journal:  J Am Coll Cardiol       Date:  2000-02       Impact factor: 24.094

5.  A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.

Authors:  R Morishita; G H Gibbons; M Horiuchi; K E Ellison; M Nakama; L Zhang; Y Kaneda; T Ogihara; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

6.  In vivo identification of a negative regulatory element in the mouse renin gene using direct gene transfer.

Authors:  T Yamada; M Horiuchi; R Morishita; L Zhang; R E Pratt; V J Dzau
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

7.  Antisense oligonucleotides to the p65 subunit of NF-kB inhibit human vascular smooth muscle cell adherence and proliferation and prevent neointima formation in rat carotid arteries.

Authors:  M V Autieri; T L Yue; G Z Ferstein; E Ohlstein
Journal:  Biochem Biophys Res Commun       Date:  1995-08-24       Impact factor: 3.575

8.  Pharmacokinetics of antisense oligodeoxyribonucleotides (cyclin B1 and CDC 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery.

Authors:  R Morishita; G H Gibbons; Y Kaneda; T Ogihara; V J Dzau
Journal:  Gene       Date:  1994-11-04       Impact factor: 3.688

9.  Sequence-specific interaction of alpha-beta-anomeric double-stranded DNA with the p50 subunit of NF kappa B: application to the decoy approach.

Authors:  H Tanaka; P Vickart; J R Bertrand; B Rayner; F Morvan; J L Imbach; D Paulin; C Malvy
Journal:  Nucleic Acids Res       Date:  1994-08-11       Impact factor: 16.971

Review 10.  Late graft failure of autologous vein grafts for arterial occlusive disease: clinical and experimental studies.

Authors:  H Itoh; K Komori; T Onohara; S Funahashi; K Okadome; K Sugimachi
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

View more
  4 in total

Review 1.  Therapeutic approach against intimal hyperplasia of vein grafts through endothelial nitric oxide synthase/nitric oxide (eNOS/NO) and the Rho/Rho-kinase pathway.

Authors:  Masayuki Sugimoto; Dai Yamanouchi; Kimihiro Komori
Journal:  Surg Today       Date:  2009-05-27       Impact factor: 2.549

2.  Temporal network based analysis of cell specific vein graft transcriptome defines key pathways and hub genes in implantation injury.

Authors:  Manoj Bhasin; Zhen Huang; Leena Pradhan-Nabzdyk; Junaid Y Malek; Philip J LoGerfo; Mauricio Contreras; Patrick Guthrie; Eva Csizmadia; Nicholas Andersen; Olivier Kocher; Christiane Ferran; Frank W LoGerfo
Journal:  PLoS One       Date:  2012-06-15       Impact factor: 3.240

3.  The effect of NF-κB antisense oligonucleotide on transdifferentiation of fibroblast in lung tissue of mice injured by bleomycin.

Authors:  Yan Zhou; Xiaoye Zhang; Mingqi Tan; Rui Zheng; Li Zhao
Journal:  Mol Biol Rep       Date:  2014-03-02       Impact factor: 2.316

Review 4.  Nano and microtechnologies for the delivery of oligonucleotides with gene silencing properties.

Authors:  Giuseppe De Rosa; Maria Immacolata La Rotonda
Journal:  Molecules       Date:  2009-07-29       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.